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Objective: Recently, therapies targeting the biological characteristics of individual cancers according to markers
indicating underlying molecular biological mechanisms have become available. Core needle biopsy (CNB) is widely
used, not only to diagnose, but also to determine therapeutic strategies, in patients with breast cancer. Although
the diagnostic accuracy of CNB is acceptably high, false-negative results have occasionally been encountered.
Methods: The results of adjunctive imprint cytology (AIC) coinciding with CNB in 2,820 patients suspected to have
breast cancer were retrospectively reviewed. The feasibility and clinical usefulness of AIC-assisted diagnosis were
analyzed.
Results: Fourteen-hundred and sixty-four cases were diagnosed as not malignant using CNB alone. Forty-seven of
1464 cases were suspected to be malignant on a cytological review of AIC, and 42 were confirmed to be breast
cancer on additional biopsies. The combination of CNB and AIC achieved a sensitivity of 100% (1398/1398) and a
specificity of 99.6% (1417/1422). Small lesions and large noninvasive- or scirrhous-type carcinomas were the
common features of the CNB-negative/AIC-positive cases.
Conclusions: Adjunctive imprint cytodiagnosis is a simple and easy procedure that assists the pathological
diagnosis of breast cancer using CNB and therefore serves as a possible novel standard application.
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Recently, molecular biological mechanisms involved in
the growth and metastasis of breast cancer have been
intimately elucidated. Therapies targeting the biological
characteristics of individual cancers according to markers
indicating underlying molecular biological mechanisms
have become available. For instance, hormone, chemo and
HER2/neu molecular-targeting therapies are widely used
based on the expression states of estrogen receptor (ER),
progesterone receptor (PR), Ki67 and the HER2/neu
expression status in cancer cells (Sorlie et al. 2003;
Bauer et al. 2007; Rastogi et al. 2008; Perez et al. 2010;
Abd El-Rehim et al. 2005; Mattie et al. 2006).* Correspondence: spqv9ke9@view.ocn.ne.jp
1Department of Surgical Oncology, Osaka City University Graduate School of
Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan
Full list of author information is available at the end of the article
© 2013 Kashiwagi et al.; licensee Springer. This
Attribution License (http://creativecommons.or
in any medium, provided the original work is pMoreover, the expressions of these molecules are also
known to have roles as prognostic indicators (Rakha
et al. 2006; Sørlie et al. 2006; Rakha et al. 2007). Hence,
molecules used as therapeutic targets, as well as prognos-
tic predictors, can be determined prior to the initiation of
tailor-made therapies. In order to obtain such molecular
information and determine an accurate pathological diag-
nosis, acquiring sufficient amounts of tissue samples from
individual tumors is required. Although open biopsy and
Mammotome® (MMT) are the best procedures to acquire
large amounts of tissue samples (Brem et al. 2001;
Verkooijen 2002; Hoorntje et al. 2003), it is not practical
to apply these invasive and expensive procedures to every
tumor suspected of being breast cancer. The type of
subjects considered for these procedures should therefore
be limited.is an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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sally performed to diagnose breast cancer. We have been
employing CNB as a routine diagnostic procedure in our
institute since 2007. For the experienced hand, performing
the CNB procedure is very easy, minimally invasive, safe
and inexpensive when compared with open biopsy or
MMT (Brem et al. 2001). Previous reports of CNB have
shown a sensitivity of as high as 86–90% and a specificity
of 89–96% (Westenend et al. 2001; Hatada et al. 2000;
Ballo & Sneige 1996). Furthermore, the precise character-
istics of cancer cells can be investigated from the tissue
samples obtained with CNB (Varga et al. 2005; Taucher
et al. 2003; Cahill et al. 2006).
However, at the same time, false-negative results have
occasionally been encountered in the diagnosis of breast
cancer using CNB (Varga et al. 2005; Taucher et al.
2003). The obtained tissue samples are small, and it is
sometimes difficult to demonstrate a suitable cut surface
on a slide for pathological investigation. Therefore, most
diagnostic errors from CNB result from failures to investi-
gate whole specimens due to improperly obtained samples
or inadequately presented histological specimens. To im-
prove the diagnostic accuracy of CNB, adjunctive imprint
cytodiagnosis (AIC) has been used in our institute. We ex-
perienced a number of cases in which significant benefits
were gained using this procedure.
We herein retrospectively reviewed and evaluated the
usefulness and availability of AIC-assisted CNB for making
accurate diagnoses of breast cancer.
Materials and methods
Patient background
The subjects included 2,720 consecutive patients suspected
to have breast cancer who underwent CNB and imprint
cytodiagnosis at our department between May 2007 and
March 2013. Suspicion of the disease was determined
on either physical examination, CT scan, magnetic res-
onance imaging or US. Every lesion was clearly demon-
strated and fully investigated on US before any biopsies
were performed. Only patients from whom written in-
formed consent was adequately obtained by explaining
the procedures and possible outcomes were included. WeFigure 1 Core needle biopsy and adjunctive imprint cytology method
Immediately after the tissue sample itself and the needle were touched theperformed biopsies in cases of category 4–5 BI-RADS
classification (Ball et al. 2002; Orel et al. 1999). Several
patients with tumors classified as category 3 were also in-
cluded according to the recommendations of supervising
doctors. One-hundred and seventy two patients were ex-
cluded from undergoing CNB and directly sent to undergo
vacuum-assisted biopsies such as MMT or the self-
contained vacuum-assisted biopsy system (Vacora®). These
patients were suspected to have ductal carcinoma in situ
with predominant US findings of ductal dilatation without
clear tumor formation. No complications were observed
in association with the procedures. No patient diagnosed
with benign disease developed malignant disease during
the follow-up period of two to 45 months.Method of CNB and adjunctive imprint cytology (AIC)
In each patient, local infiltration anesthesia was admin-
istered with 0.5% epinephrine-containing lidocaine
hydrochloride for the skin and puncture pathways and
around the lesions. Then, 1.5 mm of skin was excised
for biopsy using an ultrasound-guided 16 G biopsy nee-
dle. In principle, two biopsies were sampled from each
lesion (Figure 1a). In each case, immediately after the
tissue sample was taken out from the needle, the tissue
sample and the needle were touched and rolled over on
a slide glass and fixed with 95% ethanol (Figure 1b). A
cytological diagnosis was made based on the investiga-
tion of Papanicolaou stained specimens by approved
cytologists and cytopathologists. The specimens were
classified into five categories according to the general
rules of clinical and pathological recording of breast
cancer (Wang & Ducatman 1998): “normal or benign”,
“indeterminate”, “suspicious for malignancy” and “malig-
nant”. The tissue samples were fixed in 10% buffered for-
malin. Several serial HE-stained slides were obtained from
formalin-fixed and paraffin-embedded tissue samples for
pathological examination by more than two pathologists.
For the tissue samples diagnosed as cancerous, immuno-
histochemical staining against ER, PR, Ki67 and HER2/
neu was conducted in addition to the routine pathological
diagnosis.s. In principle, two biopsies were sampled from the each lesion (a).
y were rolled over on a slide glass and fixed with 95% ethanol (b).
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A review of the diagnoses made with CNB demonstrated
that, of all the 2,820 cases, 1,464 (51.9%) were benign
and 1356 (48.1%) were malignant. CNB alone showed a
sensitivity of 96.6% (1351/1398), a specificity of 99.6%
(1417/1422) and a false-negative rate of 3.4% (47/1398).
Of the malignant cases, 47 (1.7%) were diagnosed as be-
nign on CNB and suspected of being malignant on AIC.
Ultimately, 42 of these 47 patients (89.4%) were revealed
to have breast cancer (Figure 2).
Table 1 shows the clinico-pathological backgrounds
of the 42 cases diagnosed to have breast cancer on
AIC. All of the patients were female. Their ages ranged
from 30 to 82 (mean: 61.0) years. Thirteen patients
were pre-menopausal and twenty-nine patients were
post-menopausal. The tumor diameters measured be-
tween 0.4 and 8.0 (mean: 1.9) cm. Nine cases involved
tumors measuring less than 1 cm in diameter and 26
(61.9%) cases involved tumors measuring less than 2 cm
in diameter. In sixteen cases (38.1%), no tumors were
found within the tissue samples obtained with CNB. Ten
cases (23.8%) were diagnosed as having benign hyperplas-
tic lesions such as adenosis or hyperplasia. And two cases
(4.8%) were necrotic tissue. Atypical cell clusters were
found in the CNB specimens of the fourteen remaining
cases (33.3%). Twenty tumors were diagnosed as “suspi-
cious for malignancy” and twenty-two tumors were diag-
nosed as “malignant” according to the AIC specimens.
Diagnoses of breast cancer were obtained with MMT bi-
opsies before surgery, and 33 invasive ductal carcinomas
(78.6%) and nine non-invasive ductal carcinoma in situ
(21.4%) were identified on the final pathological investiga-
tions of the surgical specimens. ER and PR were positively
identified in 26 (61.9%) and 21 (50.0%) cases, respectively.
HER2/neu was found to be overexpressed in 12 cases
(28.6%).
In contrast, five tumors (10.6%) classified as “suspicious
for malignancy” on AIC were ultimately revealed to haveFigure 2 Schema of our diagnostic procedure was shown. A CNB diag
benign and 1356 (48.1%) were malignant. Forty-seven cases (1.7%) were di
Finally, 42 of the 47 patients (89.4%) were revealed to have breast cancer.been diagnosed correctly in the initial pathological review
of the CNB specimens. The final pathological diagnosis in
five cases was confirmed using MMT biopsies to be
benign disease (three cases of fibroadenoma and two cases
of intra ductal papilloma). Therefore, of all the 2,820 cases,
1,422 (50.4%) were ultimately diagnosed as benign and
1,398 (49.6%) were ultimately diagnosed as malignant.
Forty-two false-negative cases on pathological review of
CNB and five false-positive cases on cytological review of
AIC were found. The combination of CNB and AIC
achieved a sensitivity of 100% (1398/1398) and a specifi-
city of 99.6% (1417/1422) (Table 2).
Figure 3 shows a representative case. A 58-year-old
female was found to have a 1.9 cm tumor on her right
breast on US. She underwent CNB on suspicion of having
breast cancer. Only a small area of atypical cell clusters
was demonstrated in the CNB sample, which was not con-
sidered an adequate quantity to diagnose the lesion as
breast cancer. On the other hand, AIC classified the tumor
as “malignant” based on the demonstration of cancerous
cells with papillary clumping. A final diagnosis of invasive
ductal carcinoma was made using MMT. This diagnosis
was consistent with the pathological features of the surgi-
cally resected specimen.
Discussion
A considerable number of cases have shown discrepan-
cies between clinical images and pathology in the diag-
nosis of breast lesions. Nevertheless, in cases with strong
clinical suspicion of malignancy, most lesions that can-
not be proven to be pathologically malignant on biopsy
are ultimately revealed to be benign. However, on some
occasions, malignant disease can only be identified after
repeated investigation, resulting in critical delays in initi-
ating anti-cancer therapy. To avoid these problems, suf-
ficient specimens should be presented for pathological
review. Open biopsy or MMT are useful methods for
obtaining adequate tissue samples to make accuratenosis demonstrated that, of all the 2,820 cases, 1464 (51.9%) were
agnosed as benign by CNB, but suspected of being malignant by AIC.
Table 1 Clinico-pathological characteristics of the patients and breast cancers identified by adjunctive imprint cytology
of the core-needle biopsied specimens
Age Menopausal CNB Dx. AIC Dx. Final Dx. Size (cm)
46 After No tumor SM IDC* 0.4
66 Post No tumor SM DCIS** 0.5
76 Post No tumor SM IDC 0.6
73 Post Intraductal papilloma M DCIS 0.7
67 Post Intraductal papilloma M IDC 0.8
70 Post Atypical cell cluster SM IDC 1.0
56 Post Atypical cell cluster M IDC 1.0
78 Post No tumor M IDC 1.0
52 Post Fibrocystic condition SM DCIS 1.0
46 After Chronic mastitis SM IDC 1.2
41 After No tumor SM IDC 1.2
68 Post Apocrine metaplasia M DCIS 1.2
71 Post Necrotic tissue SM IDC 1.2
67 Post Atypical cell cluster M IDC 1.3
77 Post Ductal hyperplasia M DCIS 1.5
51 After No tumor SM IDC 1.5
33 After Adenosis M IDC 1.6
59 Post No tumor SM IDC 1.6
51 Post Atypical cell cluster SM IDC 1.6
43 After No tumor SM DCIS 1.7
75 Post Atypical cell cluster M IDC 1.8
30 After Atypical cell cluster M IDC 1.9
58 Post Atypical cell cluster M IDC 1.9
75 Post No tumor SM IDC 1.9
74 Post Fibrocystic condition SM IDC 2.0
53 Post Atypical cell cluster SM IDC 2.0
66 Post Atypical cell cluster SM IDC 2.1
64 Post Atypical cell cluster M IDC 2.2
43 After Adenosis M IDC 2.4
42 After No tumor SM DCIS 2.4
78 Post Phyllodes suspicious SM IDC 2.4
82 Post No tumor M IDC 2.4
72 Post Atypical cell cluster M IDC 2.6
62 Post No tumor M IDC 2.9
58 Post No tumor M IDC 3.0
45 After Atypical cell cluster M IDC 3.0
54 Post No tumor SM IDC 3.5
52 Post Atypical cell cluster M IDC 3.5
47 After No tumor SM IDC 3.7
45 After Atypical cell cluster M DCIS 4.0
52 After No tumor M DCIS 5.0
77 Post Necrotic tissue M IDC 8.0
CNB core-needle biopsy, Dx. diagnosis, SM suspicious for malignancy, M malignant, AIC adjunctive imprint cytology of the core-needle biopsied, *IDC: invasive
ductal carcinoma, **DCIS: ductal carcinoma in situ.
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Table 2 The results of combination diagnosis with the
core-needle biopsy and the s adjunctive imprint cytology
CNB/AIC Benign Cancer Total
Both negative 1417 0 1417
Either positive 5 1398 1403
Total 1422 1398 2820
CNB core-needle biopsy, AIC adjunctive imprint cytology of the core-needle
biopsied specimen.
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2002; Hoorntje et al. 2003). However, it is not practical
to perform these invasive and expensive procedures in
every patient, and the simple CNB technique is universally
used as a routine method of tissue biopsy in diagnosing
the majority of cases of breast cancer (Westenend et al.
2001; Hatada et al. 2000; Ballo & Sneige 1996). Therefore,
maintaining the accuracy of pathological diagnosis with
CNB at the highest level is important.
Previous reports describing the accuracy of patho-
logical diagnosis with CNB have shown sensitivities of as
high as 86–90% and specificities of 89–96% (Westenend
et al. 2001; Hatada et al. 2000; Ballo & Sneige 1996). In
this study, our experience using CNB alone showed a
sensitivity of 96.6%, a specificity of 99.6% and a false-
negative rate of 3.4%, which was in line with the results
of previous reports. According to these observations, the
diagnostic accuracy of breast cancer with CNB seems to
have already reached a peak. Although this level of diag-
nostic accuracy is acceptable, it is true that occasional
false-negative cases still occur.
One of the most compelling explanations for the oc-
currence of false-negative CNB results is the uninten-
tional loss of the target lesion. Occasionally, only smallFigure 3 A false negative case was demonstrated. A small area of atyp
old woman with right breast tumor of 1.9 cm in maximal diameter (a). Adj
clumping (b). Invasive ductal carcinoma was clearly demonstrated in Mamcancerous tissues are included in CNB specimens, as
shown in our case. Even with careful handling, lesions
can separate from the specimens during the multitude
of steps of tissue processing. However, AIC performed
immediately after sampling using a simple imprinting
method maintains the cancerous cells within the samples,
which supplements the demerits of CNB.
Several tumor features are known to exert negative
impacts on making an accurate CNB diagnosis of breast
cancer. In many cases of non-invasive ductal carcinoma,
the tumors could not be identified clearly on US (Evans
1992) or were found to display predominantly para-
tumoral features such as ductal dilatation or irregularities
(Li et al. 2010). All of these features can be evaluated be-
fore performing CNB, and alternate methods should be
implemented such as MMT or Vacora® (Salem et al. 2009;
Wang et al. 2009; Hauth et al. 2008), as stated in the text.
On the other hand, several factors might disturb the
process of acquiring appropriate tissue specimens for
CNB, even when a clear view of the subject is achieved.
Sometimes, needles slip on surfaces or cannot penetrate
hard lesions (Ljung et al. 2001). The inability to prevent
the patient from moving or to secure the puncture devise
might result in the failure to obtain tumor-rich material
(Ljung et al. 2001). However, even on these occasions, can-
cer cells can be identified on the surface of the tissue sam-
ples or the needle and can be demonstrated on AIC slides.
The stroke of the needles used in this study was 22 mm
long. Therefore, non-tumorous tissues were often in-
cluded when performing CNB of small lesions. Similar
problems appeared when the tumors consisted of mixtures
of scattered cancer cells and matrices, such as in cases of
non-invasive carcinoma or sclerosing type (scatteredical cell cluster was found in the CNB specimen taken from a 58 years-
unctive imprint cytology revealed cancerous cells with papillary
motome® (c) and resected specimens (d).
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carcinoma. On these occasions, the cancer nests occupied
only small parts of the specimens, and the targets could
not be presented appropriately on the tissue slides for
microscopic examination. For these lesions, AIC might
therefore have been significantly effective.
The use of cytological examination has critical de-
merits for investigating the tissue structures of lesions,
an important factor used to distinguish breast cancer
from benign disease (Ogawa et al. 1998). The experience
and individual particularity of the cytologist may increase
the false-positive rate of cytological diagnosis, especially
for organs, such as the mammary glands, that are highly
dependent on hormonal circumstances (Ljung et al. 2001;
Pisano et al. 2001; Giard & Hermans 1992). Therefore,
problems remain in the diagnosis of breast cancer using
FNA alone. At the same time, cytological diagnosis has
superiorities in its ability to oversee whole specimens at a
glance, its facility and its non-invasiveness. In several pre-
vious reports, the usefulness of AIC for diagnosing cancer
involvement in the sentinel lymph nodes has been de-
scribed (Motomura et al. 2000; Llatjós et al. 2002; Lee
et al. 2002). A similar technique was used in the present
study in order to supplement the weak points of patho-
logical diagnosis using CNB.
The use of AIC in combination with CNB does not add
any burdens to the patient’s body and can be performed
with small expense. The procedure is not complicated and
only requires rolling the tissue samples on the slide glass
while confirming whether the obtained tissue specimens
are sufficient. Moreover, we demonstrated significant clin-
ical benefits of AIC in improving the pathological diagno-
sis of breast cancer.
In the present study, we described 42 cases of breast
cancer identified using AIC in combination with CNB. No
special features in the backgrounds of the patients were
observed, indicating the universal applicability of this sim-
ple method. More than half of the tumors in the present
study measured less than 2 cm in diameter, and all tumors
measuring more than 2 cm in diameter showed either
ductal carcinoma in situ or sclerosing type, histologically.
As described earlier, it has been clearly demonstrated that
AIC has a significant additional impact for diagnosing le-
sions with characteristics that indicate possible difficulties
in making an accurate diagnosis with CNB alone. In this
study, we experienced five false-positive cases with AIC.
After confirming the final pathology using tissue obtained
by MMT, both cases were revealed to have been diagnosed
correctly on CNB. The diseases observed in these five
cases (three cases of fibroadenoma and two cases of intra
ductal papilloma) tend to be overly diagnosed using
cytology (Giard & Hermans 1992). It may be possible to
omit performing MMT with more intimate mutual
consultations between surgeons and pathologists.We herein retrospectively examined the usefulness and
applicability of adjunctive imprint cytodiagnosis of core
needle biopsied specimens in the diagnosis of breast
cancer and found significant benefits for this technique in
improving the ability to make an accurate diagnosis. To
our knowledge, no previous reports have been published
on these issues. Adjunctive imprint cytodiagnosis is a
simple and easy procedure that assists the pathological
diagnosis of breast cancer with CNB and therefore serves
as a possible novel standard application.
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